The Shiley-Marcos Alzheimer’s Disease Research Center (ADRC) was established in 1984 as one of the original five Alzheimer’s Disease Centers supported by the National Institute on Aging, a branch of the National Institutes of Health.
That year, under the direction of Robert Katzman, M.D., late Professor Emeritus in Neurosciences, a number of scientists and scholars renowned for their work in Alzheimer’s disease and aging assembled at UCSD to conduct investigations into the etiology and effects of this devastating disease.
Working with multiple facilities around the country, our clinicians and basic researchers have been instrumental in helping the scientific community understand the clinical presentation and the basic biology of the disease. Our clinical studies have also uncovered information that has led to the development of therapies that may help slow the progression of the disease and, in some cases, improve memory.
The center’s longitudinal study enrolls both people with Alzheimer’s disease (AD) and related dementias as well as control subjects, who are fluent in either English or Spanish. Since its inception, more than 1,500 volunteers have participated in our research studies, and more than 200 participants have been seen at our Hispanic satellite clinic in Chula Vista, California.
Give to UCSD's Shiley-Marcos Alzheimer's Disease Research Center